MX393983B - Bibliotecas de polipéptidos modulares y métodos para elaborarlas y usarlas - Google Patents

Bibliotecas de polipéptidos modulares y métodos para elaborarlas y usarlas

Info

Publication number
MX393983B
MX393983B MX2018002596A MX2018002596A MX393983B MX 393983 B MX393983 B MX 393983B MX 2018002596 A MX2018002596 A MX 2018002596A MX 2018002596 A MX2018002596 A MX 2018002596A MX 393983 B MX393983 B MX 393983B
Authority
MX
Mexico
Prior art keywords
modular polypeptide
methods
polypeptide libraries
synthetic modular
making
Prior art date
Application number
MX2018002596A
Other languages
English (en)
Spanish (es)
Other versions
MX2018002596A (es
Inventor
Kole T Roybal
Russell M Gordley
Scott M Coyle
Wendell A Lim
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of MX2018002596A publication Critical patent/MX2018002596A/es
Publication of MX393983B publication Critical patent/MX393983B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/31—Chimeric antigen receptors [CAR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4202—Receptors, cell surface antigens or cell surface determinants
    • A61K40/421—Immunoglobulin superfamily
    • A61K40/4211—CD19 or B4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/179—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
MX2018002596A 2015-09-01 2016-08-31 Bibliotecas de polipéptidos modulares y métodos para elaborarlas y usarlas MX393983B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562212999P 2015-09-01 2015-09-01
PCT/US2016/049745 WO2017040694A2 (en) 2015-09-01 2016-08-31 Modular polypeptide libraries and methods of making and using same

Publications (2)

Publication Number Publication Date
MX2018002596A MX2018002596A (es) 2019-02-07
MX393983B true MX393983B (es) 2025-03-24

Family

ID=58188233

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018002596A MX393983B (es) 2015-09-01 2016-08-31 Bibliotecas de polipéptidos modulares y métodos para elaborarlas y usarlas
MX2022007861A MX2022007861A (es) 2015-09-01 2018-03-01 Bibliotecas de polipeptidos modulares y metodos para elaborarlas y usarlas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022007861A MX2022007861A (es) 2015-09-01 2018-03-01 Bibliotecas de polipeptidos modulares y metodos para elaborarlas y usarlas.

Country Status (14)

Country Link
US (2) US11560561B2 (https=)
EP (3) EP3344803B1 (https=)
JP (2) JP6878408B2 (https=)
KR (2) KR102659574B1 (https=)
CN (2) CN108138362B (https=)
AU (2) AU2016315941B2 (https=)
CA (2) CA3227545A1 (https=)
EA (1) EA201890611A1 (https=)
ES (1) ES2887593T3 (https=)
IL (2) IL293963A (https=)
MX (2) MX393983B (https=)
PT (1) PT3344803T (https=)
SG (1) SG10201913915WA (https=)
WO (1) WO2017040694A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2875747T3 (es) 2016-01-11 2021-11-11 Univ Leland Stanford Junior Proteínas quiméricas y métodos de inmunoterapia
WO2017123559A2 (en) 2016-01-11 2017-07-20 The Board Of Trustees Of The Leland Stanford Junior University Chimeric proteins and methods of regulating gene expression
WO2019020733A1 (en) * 2017-07-26 2019-01-31 Cellectis METHODS OF IMMUNE CELL SELECTION OF THE ANTIGEN-DEPENDENT CHIMERIC ANTIGENIC RECEPTOR (CAR)
WO2020036181A1 (ja) * 2018-08-13 2020-02-20 Ｓｐｉｂｅｒ株式会社 細胞を単離又は同定する方法及び細胞集団
KR20210060541A (ko) * 2018-09-19 2021-05-26 더 유니버시티 오브 홍콩 개선된 고처리량 조합 유전적 변형 시스템 및 최적화된 Cas9 효소 변이체
GB201816522D0 (en) 2018-10-10 2018-11-28 Autolus Ltd Methods and reagents for analysing nucleic acids from single cells
US20220017894A1 (en) * 2018-11-06 2022-01-20 Gordian Biotechnology, Inc. Compositions and methods for in vivo screening of therapeutics
CN109576292B (zh) 2018-12-21 2022-11-29 深圳市爱思迪生物科技有限公司 一种抗体文库的构建方法及其应用
JP6821230B2 (ja) * 2019-02-04 2021-01-27 国立大学法人愛媛大学 ＣＡＲライブラリおよびｓｃＦｖの製造方法
US20200325241A1 (en) * 2019-04-11 2020-10-15 Massachusetts Institute Of Technology Novel chimeric antigen receptors and libraries
AU2020265583A1 (en) * 2019-04-28 2021-12-02 Earlydiagnostics, Inc. Methods for library preparation to enrich informative DNA fragments using enzymatic digestion
US20220396609A1 (en) * 2019-11-01 2022-12-15 Senti Biosciences, Inc. Chimeric receptor sensors
CN111304244A (zh) * 2019-11-13 2020-06-19 沣潮医药科技（上海）有限公司 携带基因元件组合的载体组件、受体细胞文库、制备和筛选方法及用途
US11739370B1 (en) 2020-01-10 2023-08-29 Gordian Biotechnology, Inc. Methods and compositions for in vivo screening of therapeutics through spatial transcriptomics
CN114057890A (zh) * 2020-07-31 2022-02-18 南京北恒生物科技有限公司 新型共刺激结构域及其用途
CA3255881A1 (en) 2022-06-17 2023-12-21 Insitro, Inc. In situ sequencing of RNA transcripts with non-uniform 5' ends
JP2026009432A (ja) * 2022-09-20 2026-01-21 Ｓｐｉｂｅｒ株式会社 Ｄｎａ配列のスクリーニング方法
WO2025054202A1 (en) * 2023-09-05 2025-03-13 Sana Biotechnology, Inc. Method of screening a sample comprising a transgene with a unique barcode
WO2025054284A1 (en) * 2023-09-06 2025-03-13 Baylor College Of Medicine Refinement of car constructs via barcoded screening
CN120865430A (zh) * 2024-04-30 2025-10-31 合源生物科技(天津)有限公司 一种增强型嵌合抗原受体及其应用
CN119264271B (zh) * 2024-10-08 2025-05-09 北京市神经外科研究所 一种nk细胞特异性的嵌合抗原受体及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR587222A (fr) 1923-12-21 1925-04-14 Rhodiaseta Perfectionnements dans les procédés et appareils destinés à la fabrication des fis ou filaments artificiels
US20090233806A1 (en) 1999-07-06 2009-09-17 Carr Francis J Protein isolation and analysis
US20040121324A1 (en) 2001-01-18 2004-06-24 Brenner Charles M. Barcoded synthetic lethal screening to identify drug targets
WO2003048345A1 (en) 2001-12-07 2003-06-12 Toolgen, Inc. Phenotypic screen of chimeric proteins
US7604805B2 (en) 2003-07-03 2009-10-20 Regents Of The University Of California Protein logic gates
AU2005250408B2 (en) * 2004-05-27 2010-09-23 The Trustees Of The University Of Pennsylvania Novel artificial antigen presenting cells and uses therefor
US8153598B2 (en) * 2005-10-19 2012-04-10 Intrexon Corporation PKD ligands and polynucleotides encoding PKD ligands
US8148085B2 (en) 2006-05-15 2012-04-03 Sea Lane Biotechnologies, Llc Donor specific antibody libraries
EP2069558B1 (en) 2006-10-02 2013-05-01 Sea Lane Biotechnologies,llc. Design and construction of diverse synthetic peptide and polypeptide libraries
US9051665B2 (en) * 2008-11-20 2015-06-09 Steven L. Zeichner Method for screening biomolecules
EP2436766A1 (en) * 2010-09-29 2012-04-04 Deutsches Krebsforschungszentrum Means and methods for improved protein interaction screening
CA2821299C (en) * 2010-11-05 2019-02-12 Frank J. Steemers Linking sequence reads using paired code tags
EP3736281A1 (en) 2011-02-18 2020-11-11 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
SG11201406538VA (en) * 2012-04-13 2014-11-27 Sequenta Inc Detection and quantitation of sample contamination in immune repertoire analysis
CN104769103B (zh) 2012-09-04 2018-06-08 塞勒克提斯公司 多链嵌合抗原受体和其用途
EP4303232A3 (en) * 2013-02-15 2024-04-17 The Regents of The University of California Chimeric antigen receptor and methods of use thereof
US20150011405A1 (en) 2013-07-03 2015-01-08 Atreca, Inc. Use of Nanoexpression to Interrogate Antigen Repertoires
EP3656864A1 (en) * 2014-02-14 2020-05-27 Board of Regents, The University of Texas System Chimeric antigen receptors and methods of making
WO2015163745A1 (ko) * 2014-04-25 2015-10-29 재단법인 의약바이오컨버젼스연구단 바코드 이동 분석을 위한 이중 리포터 시스템을 보유한 효모 균주
US20150315569A1 (en) * 2014-05-02 2015-11-05 The Board Of Trustees Of The Leland Stanford Junior University Method for screening a nucleic acid-programmed small molecule library

Also Published As

Publication number Publication date
US12460199B2 (en) 2025-11-04
AU2016315941A1 (en) 2018-03-08
WO2017040694A3 (en) 2017-04-20
WO2017040694A2 (en) 2017-03-09
MX2022007861A (es) 2022-07-19
KR102659574B1 (ko) 2024-04-23
JP2018525992A (ja) 2018-09-13
HK1256697A1 (zh) 2019-10-04
IL293963A (en) 2022-08-01
JP6878408B2 (ja) 2021-05-26
EP3344803B1 (en) 2021-08-04
CN114657173A (zh) 2022-06-24
HK1256838A1 (en) 2019-10-04
CN108138362B (zh) 2022-03-29
AU2022275510A1 (en) 2023-01-19
ES2887593T3 (es) 2021-12-23
MX2018002596A (es) 2019-02-07
EP3954772B1 (en) 2023-10-25
IL257453B (en) 2022-07-01
IL257453A (en) 2018-04-30
US11560561B2 (en) 2023-01-24
KR20240056636A (ko) 2024-04-30
PT3344803T (pt) 2021-09-20
EP4282979A2 (en) 2023-11-29
US20200224191A1 (en) 2020-07-16
EP3954772C0 (en) 2023-10-25
CA2995389A1 (en) 2017-03-09
EP3954772A1 (en) 2022-02-16
EP4282979A3 (en) 2024-02-28
EP3344803A4 (en) 2019-06-12
AU2016315941B2 (en) 2022-09-08
JP7397821B2 (ja) 2023-12-13
EP3344803A2 (en) 2018-07-11
CA3227545A1 (en) 2017-03-09
SG10201913915WA (en) 2020-03-30
JP2021119780A (ja) 2021-08-19
EA201890611A1 (ru) 2018-08-31
KR20180081486A (ko) 2018-07-16
CN108138362A (zh) 2018-06-08
US20230212557A1 (en) 2023-07-06
CA2995389C (en) 2024-03-12

Similar Documents

Publication Publication Date Title
MX393983B (es) Bibliotecas de polipéptidos modulares y métodos para elaborarlas y usarlas
CL2021001179A1 (es) Anticuerpos específicos para tl1a y ácidos nucleicos que los codifican (divisional de la solicitud no. 201801596).
MX2016007958A (es) Anticuerpos anti-cd3 y metodos de uso.
PL3551664T3 (pl) Przeciwciała i polipeptydy skierowane przeciwko cd127
MX2017015464A (es) Anticuerpos anti-tau y metodos de uso.
SG10202000834WA (en) Antibody constructs for cd70 and cd3
MX384419B (es) Constructos de anticuerpos para cdh19 y cd3
CL2016001868A1 (es) Proteinas de union y sus métodos de uso
HUE064332T2 (hu) In vitro és sejtalapú esszék botulinum neurotoxinok aktivitásának mérésére
MX2024011869A (es) Anticuerpos anti-tau y metodos de uso
IL280240A (en) Nef-containing t cells and methods of producing thereof
MX2017007049A (es) Anticuerpos anti-cd79b y métodos de uso.
CR20170240A (es) Anticuerpos anti-interleucina-33 y sus usos
CR20190271A (es) Anticuerpos antitau y métodos de uso
MX2022001085A (es) Anticuerpos anti-c1s humanizados y metodos para usarlos.
MX2017008817A (es) Composiciones y metodos para la glicosilacion de proteinas.
CR20150046A (es) Anticuerpos anti-cd79b e inmunoconjugados
CR20170095A (es) Anticuerpos anti-cll-1 e inmunoconjugados referencias recíprocas con solicitudes relacionadas
CU24405B1 (es) Proteínas de variantes de secuencias de aminoácidos de cry1da1 activas para lepidópteros
EP3541936C0 (en) SYSTEMS AND METHODS FOR IDENTIFYING AND EXPRESSING GENE GROUPS
IL261517A (en) Methods for modular synthesis of n-glycans and arrays thereof
EP3650533A4 (en) NEW STRAIN DEBIFIDOBACTERIUM BIFIDUM
UY34115A (es) Ensayo de la lisil oxidasa-like 2 y sus métodos de empleo
EP3356832C0 (en) BIOMARKERS AND METHODS FOR ASSESSING PSORIATIC ARTHRITIS DISEASE ACTIVITY
MX2016009911A (es) Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes.